Finding the Needle in Haystacks of Patient Big Data
October 18, 2017 | 2pm ET / 11am PT | Qlik

Join Qlik and Dark Matter to learn how Life Science and Healthcare companies use visual big data analytics to quickly explore billions of medical claims, physician and patient data to accelerate patient recruitment and meet patient accrual goals. Register now.

Elemental Impurities: Change is Coming – Are You Ready?
October 19, 2017 | 11am ET / 8am PT | West Pharmaceutical Services, Inc.

Are you ready to comply with changes to elemental impurities guidelines?  Ready or not, join Diane Paskiet and Diego Zurbriggen on October 19 at 11 a.m. ET as they discuss a comprehensive approach to elemental impurities. Register now!

Managing the Costs of Specialty Drugs
Thursday, October 26 | 11am ET / 8am PT | Elsevier

This webinar will bring together experts to offer strategies for managing the costs of developing and marketing highly specialized drugs. Join us and learn more about the growing use of specialty pharmacies and how they can be leveraged to bring costs down in drug development and marketing. Register now.

Shifting Pharma’s Mindset: Viewing Quality as Value Creator, Not Cost
November 1, 2017 | 10am ET / 7am PT | Capsugel – Now a Lonza Company

This webinar will focus on quality as a way to manage costs and create a new competitive advantage through leveraging the expertise of suppliers in providing the best combination of product and process understanding. Register Now!

Single Source of Truth: the Future of TMF automation
Wednesday, November 15 | 11am ET / 8am PT | Medidata

Join us for this webinar and learn how Medidata eTMF manages all your data and content - from study planning to close - on one platform, accelerating study startup and ensuring compliance & inspection readiness. Register now!

Understanding Common Causes of Failure in Depression Studies
October 17, 2017 | 11am ET / 8am PT | Rho

The failure rate of clinical studies in depression is high, and placebo response is often blamed.  In this webinar, Dr. Jack Modell, a board certified psychiatrist with more than 35 years of experience in clinical research and patient care, discusses why there is more to the story than placebo response. Register now. 

Effectively Deliver Diagnostic-Enabled Therapies to Market
October 17-19, 2017 | Boston, MA | World CDx

Bringing together thought leaders in the biomarker, CDx and precision medicine fields, World CDx remains dedicated to helping large pharma and biotech drug developers turn predictive biomarkers into clinically validated companion diagnostic assays for their precision medicine candidates. Register now.

Enhance the Application of Predictive, Monitoring & Resistance Biomarkers
October 17-19, 2017 | Boston, MA | Clinical Biomarkers

Taking place at World CDx, Clinical Biomarkers Summit will unite large pharma and biotech drug developers to help them more granularly and robustly develop biomarker signatures through the discovery, development and clinical validation of predictive, monitoring and resistance biomarkers. Register now.

Using Real-World Evidence in Payer Negotiations: What’s in Your Playbook?

Payers evaluate real-world evidence differently than regulators.  Explore how RWE can help you align with payers on product environment & value vs competitors, defending product positioning, & demonstrating value. Make the most of  RWE in payer negotiations to maximize your market access and success. Read more.

Veeva 2017 Annual CRO Report: CROs lead the drive to a unified clinical model
Veeva Systems

CROs are leading an industry wide shift to modernize clinical systems and clinical trial processes.  Find out why 100% of CRO respondents report the need to unify clinical applications, including CTMS, EDC, and eTMF.  Read report.

[Infographic] Global Medication Adherence Insights: Real-time Stats on Medisafe that Pharma Should Know
October 11, 2017 | Medisafe

New insights just released by Medisafe show why patients say they skip doses -- and it’s not always about cost. You’ll see new adherence data by country, therapeutic area, and more. Download now.

Institutionalizing Real-World Evidence

In the quest to understand how a therapeutic intervention performs in actual use – in real medical practice outside the controlled environment of clinical trials – many life sciences organizations are stymied. They rely on one-off processes, disconnected tools, costly and redundant data stores, and ad hoc discovery methods. Download now to read more.

Register Today – ISPE 2017 Annual Meeting
Oct. 29th - Nov. 1st, 2017 | San Diego, CA | ISPE

Attend the pharma manufacturing industry’s premier event of the year! Hear regulatory perspectives and engage in open discussions with regulators and pharma and bio-pharma industry experts. Make the most of the great networking opportunities and explore innovative products and services in our Expo Hall. Register Now!

Paid Marketplace
Patient engagement through sponsored content on Inspire:

A case of 29X increase in relative effectiveness

Which Product to Develop? Product Selection and the Importance of Early Strategic Design for Success
Available On-Demand | Camargo

This webinar will benefit executives at Biotech and Pharmaceutical companies interested in growth through pipeline expansion or new products. With a change in indication, therapeutic area, dosage form, or other innovation, products developed via the US 505(b)(2) regulatory pathway gain the advantage of utilizing appropriate existing literature to meet safety and efficacy claims. But in order to be beneficial, 505(b)(2) product development must utilize an early heavy strategic approach to enable a lower cost, lower risk, and faster path to regulatory approval and market.